Item 1.01. Entry into a Material Definitive Agreement.
On October 12, 2021, IX Acquisition Corp. (the "Company") consummated its
initial public offering ("IPO") of 23,000,000 units (the "Units"), including the
issuance of 3,000,000 Units as a result of the underwriters' exercise of their
over-allotment option in full. Each Unit consists of one Class A ordinary share
of the Company, par value $0.0001 per share (the "Class A Ordinary Shares"), and
one-half of one redeemable warrant of the Company (each whole warrant, a
"Warrant"), with each Warrant entitling the holder thereof to purchase one Class
A Ordinary Share for $11.50 per share, subject to adjustment. The Units were
sold at a price of $10.00 per Unit, generating gross proceeds to the Company of
$230,000,000.
In connection with the IPO, the Company entered into the following agreements,
forms of which were previously filed as exhibits to the Company's Registration
Statement on Form S-1 (File No. 333-259567) for the IPO, initially filed with
the U.S. Securities and Exchange Commission (the "Commission") on September 16,
2021, as amended (the "Registration Statement"):
? An Underwriting Agreement, dated October 6, 2021, by and between the
Company and Cantor Fitzgerald & Co. ("Cantor"), as representative of the
underwriters, a copy of which is attached as Exhibit 1.1 hereto and
incorporated herein by reference.
? A Warrant Agreement, dated October 6, 2021, by and between the Company and
Continental Stock Transfer & Trust Company, as warrant agent, a copy of
which is attached as Exhibit 4.1 hereto and incorporated herein by
reference.
? A Letter Agreement, dated October 6, 2021, (the "Letter Agreement"), by
and among the Company, its executive officers, its directors and IX
Acquisition Sponsor LLC (the "Sponsor"), a copy of which is attached as
Exhibit 10.1 hereto and incorporated herein by reference.
? An Investment Management Trust Agreement, dated October 6, 2021, by and
between the Company and Continental Stock Transfer & Trust Company, as
trustee, a copy of which is attached as Exhibit 10.2 hereto and
incorporated herein by reference.
? A Registration Rights Agreement, dated October 6, 2021, by and between the
Company, the Sponsor, Cantor, Odeon Capital Group, LLC ("Odeon") and the
other holders party thereto, a copy of which is attached as Exhibit 10.3
hereto and incorporated herein by reference.
? A Private Placement Warrants Purchase Agreement, dated October 6, 2021, by
and between the Company and the Sponsor (the "Sponsor Private Placement
Warrants Purchase Agreement"), a copy of which is attached as Exhibit 10.4
hereto and incorporated herein by reference.
? A Private Placement Warrants Purchase Agreement, dated October 6, 2021, by
and among the Company, Cantor and Odeon (the "Underwriters Private
Placement Warrants Purchase Agreement"), a copy of which is attached as
Exhibit 10.5 hereto and incorporated herein by reference.
? An Administrative Services Agreement, dated October 6, 2021, by and
between the Company and IX Acquisition Services LLC (the "Administrative
Services Agreement"), a copy of which is attached as Exhibit 10.6 hereto
and incorporated herein by reference.
? A Capital Commitment Agreement, dated October 6, 2021, by and between the
Company and the Sponsor (the "Capital Commitment Agreement"), a copy of
which is attached as Exhibit 10.7 hereto and incorporated herein by
reference.
Item 3.02. Unregistered Sales of Equity Securities.
Simultaneously with the closing of the IPO, pursuant to the Sponsor Private
Placement Warrants Purchase Agreement, the Company completed the private sale of
6,150,000 warrants (the "Sponsor Private Placement Warrants") to the Sponsor at
a purchase price of $1.00 per Private Placement Warrant, generating gross
proceeds to the Company of $6,150,000. In addition, simultaneously with the
closing of the IPO, pursuant to the Underwriters Private Placement Warrants
Purchase Agreement, the Company completed the private sale of an aggregate of
1,000,000 warrants (the "Underwriters Private Placement Warrants" and together
with the Sponsor Private Placement Warrants, the "Private Placement Warrants")
to Cantor and Odeon at a purchase price of $1.00 per Private Placement Warrant,
generating gross proceeds to the Company of $1,000,000.
The Private Placement Warrants are identical to the Warrants included as part of
the Units sold in the IPO, except that the Private Placement Warrants, so long
as they are held by the Sponsor or its permitted transferees, (i) are not
redeemable by the Company, (ii) may not (including the Class A Ordinary Shares
issuable upon exercise of the warrants), subject to certain limited exceptions,
be transferred, assigned or sold until 30 days after the completion of the
Company's initial business combination, (iii) may be exercised on a cashless
basis and (iv) are entitled to registration rights. No underwriting discounts or
commissions were paid with respect to such sale. The issuance of the Private
Placement Warrants was made pursuant to the exemption from registration
contained in Section 4(a)(2) of the Securities Act of 1933, as amended.
Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
In connection with the IPO, on October 6, 2021, Guy Willner, Karen Bach, Ian
Spence, Andrew Bartley, Eduardo Marini and Shannon Grewer (collectively, the
"Directors") were appointed to the board of directors of the Company (the
"Board"). The Board has determined that Ian Spence, Eduardo Marini, Shannon
Grewer and Andrew Bartley are independent directors within the meaning of
applicable SEC and Nasdaq rules. Effective October 6, 2021, Andrew Bartley,
Shannon Grewer and Ian Spence were appointed to the Board's Audit Committee,
with Andrew Bartley serving as chair of the Audit Committee. Effective October
6, 2021, Andrew Bartley, Shannon Grewer and Ian Spence were appointed to the
Board's Compensation Committee, with Shannon Grewer serving as chair of the
Compensation Committee.
Following the appointment of the Directors, the Board is comprised of the
following three classes: the term of office of the first class of directors,
Class I, consists of Eduardo Marini and Ian Spence, and will expire at the
Company's first annual meeting of shareholders; the term of office of the second
class of directors, Class II, consists of Shannon Grewer and Andrew Bartley, and
will expire at the Company's second annual meeting of shareholders; and the term
of office of the third class of directors, Class III, consists of Guy Willner,
Karen Bach and Noah Aptekar, and will expire at the Company's third annual
meeting of shareholders.
On October 6, 2021, in connection with his or her appointment to the Board, each
Director entered into the Letter Agreement as well as an indemnity agreement
with the Company in the form previously filed as Exhibit 10.6 to the
Registration Statement.
Other than the foregoing, none of the Directors are party to any arrangement or
understanding with any person pursuant to which they were appointed as directors
nor are they party to any transactions required to be disclosed under Item
404(a) of Regulation S-K involving the Company.
The foregoing descriptions of the Letter Agreement and the form of indemnity
agreement do not purport to be complete and are qualified in their entireties by
reference to the Letter Agreement and form of indemnity agreement, copies of
which are attached as Exhibit 10.1 hereto and Exhibit 10.6 to the Registration
Statement, respectively, and are incorporated herein by reference.
Item 5.03. Amendments to Certificate of Incorporation or Bylaws; Change in
Fiscal Year.
On October 6, 2021, in connection with the IPO, the Company adopted its Second
Amended and Restated Memorandum and Articles of Association (the "Amended
Charter"), effective the same day. The terms of the Amended Charter are set
forth in the Registration Statement and are incorporated herein by reference. A
copy of the Amended Charter is attached as Exhibit 3.1 hereto and incorporated
herein by reference.
Item 8.01. Other Events.
A total of $231,150,000, comprised of $224,000,000 of the proceeds from the IPO
(which amount includes $12,100,000 of the underwriters' deferred discount) and
$7,150,000 of the proceeds of the sale of the Private Placement Warrants, was
placed in a trust account at J.P. Morgan Chase Bank, N.A. maintained by
Continental Stock Transfer & Trust Company, acting as trustee. Except with
respect to interest earned on the funds held in the trust account that may be
released to the Company to pay its taxes and up to $100,000 of interest to pay
dissolution expenses, the funds held in the trust account will not be released
from the trust account until the earliest of (i) the completion of the Company's
initial business combination, (ii) the redemption of any of the Class A Ordinary
Shares included in the Units sold in the IPO (the "public shares") properly
submitted in connection with a shareholder vote to amend the Company's Amended
Charter (A) to modify the substance or timing of the Company's obligation to
redeem 100% of the public shares if it does not complete its initial business
combination within 18 months from the closing of the IPO or (B) with respect to
any other material provisions relating to shareholders' rights or pre-initial
business combination activity or (iii) the redemption of the Company's public
shares if it is unable to complete its initial business combination within 18
months from the closing of the IPO, subject to applicable law.
On October 6, 2021, the Company issued a press release announcing the pricing of
the IPO, a copy of which is attached as Exhibit 99.1 to this Current Report on
Form 8-K.
On October 12, 2021, the Company issued a press release announcing the closing
of the IPO, a copy of which is attached as Exhibit 99.2 to this Current Report
on Form 8-K.
© Edgar Online, source Glimpses